GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BB Biotech BION.SW · CHF

N/A · SIX · 🇨🇭 Switzerland

Compare

53.50

+3.68%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

10 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 3Strong buy
  • 6Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Last close 53.50Average target 58.28

Low
48.18
Average
58.28
Median
58.87
High
69.30

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028
RevenueCHF 1.28bnCHF 1.28bnCHF 1.28bn
Revenue, highestCHF 1.28bnCHF 1.28bnCHF 1.28bn
Revenue, lowestCHF 1.28bnCHF 1.28bnCHF 1.28bn
Earnings per share2.583.833.81
Earnings per share, highest2.583.838.11
Earnings per share, lowest2.583.83-0.49
Analysts111

Earnings against forecasts

Earnings per share by fiscal quarter

Q4 2023
Forecast-0.64
Reported1.99
Difference+410.9%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

4 / 10

Revenue growth -19.3% a year over 10 years. Return on equity 20.8%.

Model fair value

65.62

From earnings 65.62, from revenue 2,850.47.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.